Tag: cancer genetics
November 20, 2019
Cancer Genetics Reports Q3 Financial Results
Cancer Genetics has reported its Q3 strategic, financial and operating results for the third quarter ended September 30, 2019. August 20, 2019
Cancer Genetics Reports Q2 Financial Results
Cancer Genetics (NASDAQ:CGIX) has released its second quarter results for the quarter ended June 30, 2019. As quoted in the... January 29, 2019
Cancer Genetics Announces Pricing of $3.5 Million Public Offering of Common Stock
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today... December 17, 2018
Cancer Genetics Terminates Proposed Merger with NovellusDx
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
October 18, 2018
Cancer Genetics and Genecast Partner on Gene Test
Cancer Genetics announced on Thursday that it has partnered with China-based Genecast Biotechnology to market, distribute and sell the Tissue... October 18, 2018
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China
Cancer Genetics (Nasdaq:CGIX) a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced...
October 3, 2018